Rocket Pharmaceuticals Inc. Company

Rocket Pharmaceuticals is an emerging biotechnology company focused on developing first-in-class gene therapy treatment options for rare, undertreated diseases. The Company’s lead program is a lentiviral-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure andpotentially cancer.
Industry: Genomic and Epigenominc Instabillity
Headquarters: United States

Visit Website
info@rocketpharma.com
Register and Claim Ownership